What does the NextGen HemaCore Paradigm Leukemia Panel at Metropolis Healthcare include?
It evaluates a broad range of leukemia-related genes to detect mutations that influence diagnosis, prognosis, and therapy selection.
How does Metropolis Healthcare perform this leukemia gene panel?
Metropolis Healthcare uses high-coverage NGS technology along with expert bioinformatics analysis to identify clinically relevant mutations.
Who should consider taking this leukemia panel at Metropolis Healthcare?
Patients with suspected leukemia, unexplained cytopenias, abnormal blood counts, or those needing molecular profiling for treatment should consider this test.
Is fasting required for this NGS leukemia test at Metropolis Healthcare?
No, fasting is not required; a routine blood or bone marrow sample is sufficient.
How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to detailed sequencing, data analysis, and interpretation.
Can this test at Metropolis Healthcare help diagnose leukemia?
Yes, it identifies genetic mutations that support leukemia diagnosis and help classify the specific subtype.
How accurate is the NextGen sequencing used by Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through deep sequencing, strict quality controls, and expert molecular pathology oversight.
Can the results guide treatment decisions at Metropolis Healthcare?
Yes, the panel helps clinicians choose targeted therapies, plan prognosis-based strategies, and monitor disease progression.